Search for:

About
Product Portfolio
Partners
Science
- Medical information U.S.
- Publications
Investors
Join Our Team
Contact Us
- Contact Us
- Locations

Shopping cart close

About
Product Portfolio
Partners
Science
- Medical information U.S.
- Publications
Investors
Join Our Team
Contact Us
- Contact Us
- Locations

Blog

Home » SEC FIlings »

27 Mar

Additional definitive proxy soliciting materials and Rule 14(a)(12)

March 27, 2023
Posted by Ulisses

Close

Recent Posts

Gloperba Launch – Nasdaq-2024
July 10, 2024 No Comments
A randomized, placebo-controlled trial of long-acting dexamethasone viscous gel delivered by transforaminal injection for lumbosacral radicular pain
June 14, 2024 No Comments
Gout Awareness Day – May 22
May 20, 2024 No Comments
Decreased Opioid Utilization with Lidocaine Topical System 1.8% Compared to Lidocaine 5% Patch: A Retrospective Claims Analysis
March 14, 2024 No Comments
Retrospective Claims Analysis of Decreased Healthcare Visits with Lidocaine Topical System 1.8% Compared to Lidocaine 5% Patch
March 14, 2024 No Comments

Terms of Use Privacy Policy Contact

Follow us on Facebook
Follow us on LinkedIn
Contact us by email

©2024 Scilex Holding All Rights Reserved
Scilex Holding Company is the owner of Scilex Pharmaceuticals and Semnur Pharmaceuticals

Scroll To Top Sidebar

We use cookies to improve your experience on our website. By browsing this website, you agree to our use of cookies.

Accept More info